Strategic Positioning & Planning: A characteristic leading enterprise in synthetic biology
Description: To become an industrial leader integrating research, production and sales in nutrition & health, beauty care, green agriculture and medical device market segments by grasping the strategic opportunity of the rapid development of synthetic biology, introducing and incubating internationally advanced synthetic biology platforms, quickly forming a product matrix with cost advantages and functional generation gaps, and occupying key links in the middle and upper reaches of the industrial chain.
Constructed in accordance with EU cGMP quality standards
Recombinant Protein Lyophilized Powder for Injection
Genetically Engineered Injections
Highly Complex injections
Production capacity of traditional Chinese medicine preparations